<?xml version="1.0" encoding="UTF-8"?>
<ref id="B42">
 <mixed-citation publication-type="journal">
  <name>
   <surname>Hopkins</surname>
   <given-names>S</given-names>
  </name>
  <name>
   <surname>Heuman</surname>
   <given-names>D</given-names>
  </name>
  <name>
   <surname>Gavis</surname>
   <given-names>E</given-names>
  </name>
  <name>
   <surname>Lalezari</surname>
   <given-names>J</given-names>
  </name>
  <name>
   <surname>Glutzer</surname>
   <given-names>E</given-names>
  </name>
  <name>
   <surname>DiMassimo</surname>
   <given-names>B</given-names>
  </name>
  <name>
   <surname>Rusnak</surname>
   <given-names>P</given-names>
  </name>
  <name>
   <surname>Wring</surname>
   <given-names>S</given-names>
  </name>
  <article-title>Safety, plasma, pharmacokinetics, and anti-viral activity of SCY-635 in adult patients with chronic hepatitis C virus infection</article-title>
  <source>J Hepatol</source>
  <year>2009</year>
  <volume>50</volume>
  <issue>Suppl 1</issue>
  <fpage>S36</fpage>
  <comment>Smitley SaRYS, plasma, pharmacokinetics, and anti-viral activity of SCY-635 in adult patients with chronic hepatitis C virus infection</comment>
 </mixed-citation>
</ref>
